A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index
Author:
Affiliation:
1. Department of Biostatistics; University of Copenhagen; Denmark
Publisher
Wiley
Subject
Statistics and Probability,Epidemiology
Reference18 articles.
1. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker;Pepe;American Journal of Epidemiology,2004
2. Evaluating a new marker's predictive contribution;Kattan;Clinical Cancer Research,2004
3. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond;Pencina;Statistics in Medicine,2008
4. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association;Hlatky;Circulation,2009
5. Assessing the incremental role of novel and emerging risk factors;Cook;Current Cardiovascular Risk Reports,2010
Cited by 134 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Development of a plasma-free amino acid-based risk score for the incidence of cardiovascular diseases in a general population: The Nagahama study;Clinical Nutrition;2023-12
2. Association and prognostic value of multi-domain frailty defined by cumulative deficit and phenotype models in patients with heart failure;Canadian Journal of Cardiology;2023-11
3. Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma;Journal of Cancer Research and Clinical Oncology;2023-09-08
4. Methodological concerns about “concordance-statistic for benefit” as a measure of discrimination in predicting treatment benefit;Diagnostic and Prognostic Research;2023-05-16
5. Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): Explanation and Elaboration. Translation into Russian;Current Pediatrics;2023-05-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3